Loading organizations...
§ Private Equity · Beijing, China
Asset management and investment firm for institutional and private clients, specializing in private equity and cross-border investments.
CICC Capital is a Beijing, China-based asset management and investment firm that provides private equity and wealth management services to institutional and private clients. Operating as a division of the publicly listed China International Capital Corporation, the firm leverages a network of over 200 securities business offices across China and international markets. The organization focuses on equity investments and cross-border opportunities, serving high-net-worth individuals and corporate clients seeking exposure to Chinese growth. Its parent entity trades on the Hong Kong and Shanghai stock exchanges, recently ranking as the number one firm in the PRC mergers and acquisitions market according to Dealogic in the first half of 2024. The broader CICC platform was originally established in 1995 through a joint venture co-founded by Wang Qishan of China Construction Bank and John Mack of Morgan Stanley.
Yes, CICC Capital has partnered with entities such as BlueFive Capital to establish private equity funds and co-founded Sinopharm-CICC Capital with Sinopharm.
CICC Capital places a particular focus on the elderly health industry, alongside broader interests in industrial investment and strategic mergers and acquisitions.
Yes, CICC Capital has partnered with entities such as BlueFive Capital to establish private equity funds and co-founded Sinopharm-CICC Capital with Sinopharm.
CICC Capital places a particular focus on the elderly health industry, alongside broader interests in industrial investment and strategic mergers and acquisitions.
CICC Capital operates as the private equity investment management subsidiary wholly-owned by China International Capital Corporation (CICC). Established in 2017, the firm specializes in managing private equity funds and executing cross-border investments. Its strategic position within the CICC group allows it to leverage extensive financial resources and market insights to support its investment activities.
The firm's business areas encompass industrial investment and strategic mergers and acquisitions. CICC Capital focuses on identifying and investing in companies with growth potential across various sectors. This includes a particular emphasis on the elderly health industry, reflecting a targeted approach to specific market opportunities.
CICC Capital actively engages in partnerships to expand its investment reach and capabilities. For instance, it has collaborated with BlueFive Capital to establish private equity funds. Additionally, CICC Capital co-founded Sinopharm-CICC Capital with Sinopharm in October 2016, a venture focused on investments within the healthcare sector.
Its investment portfolio includes companies such as OYMotion Technologies, AccuPulse, and GigaAI, indicating an interest in advanced technology and medical device sectors. These investments span areas like therapeutic devices and surgical devices, showcasing a diversified approach within its focused industries.
CICC Capital has more than 26 tracked investments across 25 companies. The latest tracked deal is $43.4M Series D in AOSSCI in February 2026.